{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:03:34Z","timestamp":1790683414528,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100962"],"award-info":[{"award-number":["82100962"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Dental Journal"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.identj.2026.109662","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:07:28Z","timestamp":1780099648000},"page":"109662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacovigilance Analysis of Drug-Induced Stomatitis: Insights From Twenty-One Years of Real-World Data"],"prefix":"10.1016","volume":"76","author":[{"given":"Zhichao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianjie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1320-7870","authenticated-orcid":false,"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.identj.2026.109662_bib0001","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/jama.2024.0953","article-title":"Common oral conditions: a review","volume":"331","author":"Stoopler","year":"2024","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.identj.2026.109662_bib0002","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jamaoncol.2016.2103","article-title":"Mucositis (or stomatitis)","volume":"2","author":"Gupta","year":"2016","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.identj.2026.109662_bib0003","first-page":"57","article-title":"The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies","volume":"72","author":"Elad","year":"2022","journal-title":"CA: A Canc J Clin"},{"issue":"3","key":"10.1016\/j.identj.2026.109662_bib0004","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JOP.19.00652","article-title":"Management of cancer therapy-associated oral mucositis","volume":"16","author":"Brown","year":"2020","journal-title":"JCO Oncol Pract"},{"issue":"2","key":"10.1016\/j.identj.2026.109662_bib0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.semradonc.2025.02.011","article-title":"Oral mucositis in head and neck cancer patients","volume":"35","author":"Anderson","year":"2025","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"10.1016\/j.identj.2026.109662_bib0006","first-page":"195","article-title":"Unraveling the complexity of radiotherapy- and chemotherapy-induced oral mucositis: insights into pathogenesis and intervention strategies","volume":"33","author":"Jin","year":"2025","journal-title":"Support Care Cancer"},{"issue":"7","key":"10.1016\/j.identj.2026.109662_bib0007","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/jop.12910","article-title":"A review and guide to drug-associated oral adverse effects-Oral mucosal and lichenoid reactions. Part 2","volume":"48","author":"Teoh","year":"2019","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"10.1016\/j.identj.2026.109662_bib0008","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13148-025-02005-9","article-title":"Unraveling the causal association of epigenetic age acceleration with common oral diseases and its underlying mechanisms: findings from Mendelian randomization and integrative genetic analysis","volume":"17","author":"Peng","year":"2025","journal-title":"Clin Epigenet"},{"issue":"9","key":"10.1016\/j.identj.2026.109662_bib0009","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s40264-016-0444-7","article-title":"Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors","volume":"39","author":"Angamo","year":"2016","journal-title":"Drug Saf"},{"issue":"9","key":"10.1016\/j.identj.2026.109662_bib0010","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1159\/000535331","article-title":"Disproportionality analysis of stomatitis associated with anticancer drugs using the Japanese Adverse Drug Event Report Database","volume":"102","author":"Hosonaka","year":"2024","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.identj.2026.109662_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.identj.2025.100906","article-title":"National Pharmacovigilance Assessment of Oral Adverse Events Following COVID-19 Vaccination in Germany (2020-2023)","volume":"75","author":"Riad","year":"2025","journal-title":"International Dental Journal"},{"key":"10.1016\/j.identj.2026.109662_bib0012","doi-asserted-by":"crossref","unstructured":"Yu RJ, Krantz MS, Phillips EJ, Stone CA, Jr. Emerging causes of drug-induced anaphylaxis: a review of anaphylaxis-associated reports in the FDA adverse event reporting system (FAERS). J Allergy Clin Immunol Pract 2021 9(2):819\u2013829. e2.","DOI":"10.1016\/j.jaip.2020.09.021"},{"key":"10.1016\/j.identj.2026.109662_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1480269","article-title":"Drug-induced retinal vein occlusion: a disproportionality analysis from the FDA adverse event reporting system (2004-2023)","volume":"15","author":"Chen","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.identj.2026.109662_bib0014","doi-asserted-by":"crossref","first-page":"1161728","DOI":"10.3389\/fphar.2023.1161728","article-title":"Drug-induced tooth discoloration: an analysis of the US food and drug administration adverse event reporting system","volume":"14","author":"Wang","year":"2023","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.identj.2026.109662_bib0015","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3390\/ph18101580","article-title":"Disproportionality analysis of oral toxicities associated with PI3K\/AKT\/mTOR pathway inhibitors using the FAERS database","volume":"18","author":"Marni","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"10","key":"10.1016\/j.identj.2026.109662_bib0016","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000047844","article-title":"Unveiling the risk: A comprehensive analysis of drug-induced aphthous ulcers using real-world data from FAERS","volume":"105","author":"Wang","year":"2026","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.identj.2026.109662_bib0017","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc1318","article-title":"The pathobiology of mucositis","volume":"4","author":"Sonis","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.identj.2026.109662_bib0018","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.oraloncology.2012.11.008","article-title":"A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients","volume":"49","author":"Martins","year":"2013","journal-title":"Oral Oncol"},{"issue":"8","key":"10.1016\/j.identj.2026.109662_bib0019","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jclinepi.2014.03.012","article-title":"False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies","volume":"67","author":"Glickman","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.identj.2026.109662_bib0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/jcpe.70040","article-title":"Pharmacovigilance-Based identification and mechanistic exploration of periodontitis-related drugs","volume":"53","author":"Huoshen","year":"2026","journal-title":"J Clin Periodontol"},{"issue":"6","key":"10.1016\/j.identj.2026.109662_bib0021","doi-asserted-by":"crossref","first-page":"103957","DOI":"10.1016\/j.identj.2025.103957","article-title":"Identification of drugs associated with oral ulcers based on pharmacovigilance","volume":"75","author":"Zhang","year":"2025","journal-title":"Int Dental Journal"},{"issue":"6","key":"10.1016\/j.identj.2026.109662_bib0022","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.1742","article-title":"Quantitative signal detection using spontaneous ADR reporting","volume":"18","author":"Bate","year":"2009","journal-title":"Pharmacoepidemiol Drug Safety"},{"issue":"6","key":"10.1016\/j.identj.2026.109662_bib0023","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.identj.2026.109662_bib0024","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/clpt.2012.50","article-title":"Novel data-mining methodologies for adverse drug event discovery and analysis","volume":"91","author":"Harpaz","year":"2012","journal-title":"Clini Pharmacol Therap"},{"key":"10.1016\/j.identj.2026.109662_bib0025","doi-asserted-by":"crossref","first-page":"178094","DOI":"10.1016\/j.ejphar.2025.178094","article-title":"Drug-induced gingival diseases: insights from the FDA Adverse Event Reporting System (FAERS) database analysis","volume":"1005","author":"Mao","year":"2025","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.identj.2026.109662_bib0026","doi-asserted-by":"crossref","first-page":"109423","DOI":"10.1016\/j.identj.2026.109423","article-title":"Real-world sodium fluoride safety signals: dual-database pharmacovigilance","volume":"76","author":"Ning","year":"2026","journal-title":"Int Dent J"},{"key":"10.1016\/j.identj.2026.109662_bib0027","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-3-319-91442-8_8","article-title":"Everolimus","volume":"211","author":"Hasskarl","year":"2018","journal-title":"Recent Results Cancer Res"},{"issue":"2","key":"10.1016\/j.identj.2026.109662_bib0028","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.identj.2026.109662_bib0029","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","article-title":"mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway","volume":"146","author":"Peterson","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.identj.2026.109662_bib0030","doi-asserted-by":"crossref","first-page":"100007","DOI":"10.1016\/j.tmed.2026.100007","article-title":"BFAR facilitates gastric cancer progression via SPRR3 activating PI3K\/AKT\/mTOR signal pathway","volume":"1","author":"Zhang","year":"2026","journal-title":"TransMed"},{"issue":"5","key":"10.1016\/j.identj.2026.109662_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24055058","article-title":"Transcriptome sequencing reveals the mechanism behind chemically induced oral mucositis in a 3D cell culture model","volume":"24","author":"Lambros","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"Suppl 3","key":"10.1016\/j.identj.2026.109662_bib0032","doi-asserted-by":"crossref","first-page":"iii70","DOI":"10.1136\/ard.2008.098459","article-title":"The PI3K\/Akt\/mTOR pathway in innate immune cells: emerging therapeutic applications","volume":"67","author":"Weichhart","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.identj.2026.109662_bib0033","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0030-4220(90)90376-4","article-title":"An animal model for mucositis induced by cancer chemotherapy","volume":"69","author":"Sonis","year":"1990","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.identj.2026.109662_bib0034","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.20209","article-title":"Role of necroptosis in pulpitis: integration of bacterial infection, immune imbalance, and oxidative stress","volume":"13","author":"Wang","year":"2025","journal-title":"PeerJ"},{"issue":"10","key":"10.1016\/j.identj.2026.109662_bib0035","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.oraloncology.2011.08.009","article-title":"Clinical presentation and management of mTOR inhibitor-associated stomatitis","volume":"47","author":"de Oliveira","year":"2011","journal-title":"Oral Oncol"},{"issue":"12","key":"10.1016\/j.identj.2026.109662_bib0036","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2217\/fon.13.141","article-title":"Mammalian target of rapamycin inhibitor-associated stomatitis","volume":"9","author":"Boers-Doets","year":"2013","journal-title":"Future Oncol"},{"issue":"3","key":"10.1016\/j.identj.2026.109662_bib0037","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10549-013-2630-y","article-title":"Everolimus: side effect profile and management of toxicities in breast cancer","volume":"140","author":"Paplomata","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.identj.2026.109662_bib0038","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.seminoncol.2024.01.002","article-title":"CDK4\/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety","volume":"50","author":"Wekking","year":"2023","journal-title":"Semin Oncol"},{"issue":"7","key":"10.1016\/j.identj.2026.109662_bib0039","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15072005","article-title":"CDK4\/6 inhibition induces senescence and enhances radiation response by disabling DNA damage repair in oral cavity squamous cell carcinoma","volume":"15","author":"Shrivastava","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.identj.2026.109662_bib0040","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.jfma.2020.12.009","article-title":"Palbociclib induces DNA damage and inhibits DNA repair to induce cellular senescence and apoptosis in oral squamous cell carcinoma","volume":"120","author":"Wang","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"6","key":"10.1016\/j.identj.2026.109662_bib0041","doi-asserted-by":"crossref","first-page":"6556","DOI":"10.21037\/apm-21-1156","article-title":"Oral adverse effects of CDK4\/6 inhibitors among breast cancer patients: a systematic review and meta-analysis","volume":"10","author":"Long","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"1","key":"10.1016\/j.identj.2026.109662_bib0042","first-page":"72","article-title":"Cabozantinib cutaneous toxicity-comprehensive review","volume":"15","author":"Tutunaru","year":"2025","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.identj.2026.109662_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10456-009-9160-6","article-title":"Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?","volume":"13","author":"Gotink","year":"2010","journal-title":"Angiogenesis"},{"issue":"11","key":"10.1016\/j.identj.2026.109662_bib0044","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.oraloncology.2015.09.003","article-title":"Oral adverse events in cancer patients treated with VEGFR-directed multitargeted tyrosine kinase inhibitors","volume":"51","author":"Yuan","year":"2015","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.identj.2026.109662_bib0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clinthera.2005.01.005","article-title":"Capecitabine: a review","volume":"27","author":"Walko","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.identj.2026.109662_bib0046","doi-asserted-by":"crossref","first-page":"105159","DOI":"10.1016\/j.archoralbio.2021.105159","article-title":"Chemotherapy drugs and inflammatory cytokines enhance matrix metalloproteinases expression by oral mucosa cells","volume":"127","author":"Cardoso","year":"2021","journal-title":"Arch Oral Biol"},{"issue":"5","key":"10.1016\/j.identj.2026.109662_bib0047","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1600-0765.2004.00759.x","article-title":"Chlorhexidine induces DNA damage in rat peripheral leukocytes and oral mucosal cells","volume":"39","author":"Ribeiro","year":"2004","journal-title":"J Periodontal Res"},{"issue":"1","key":"10.1016\/j.identj.2026.109662_bib0048","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s13054-019-2664-6","article-title":"Oral mucositis as a pathway for fatal outcome among critically ill patients exposed to chlorhexidine: post hoc analysis of a randomized clinical trial","volume":"23","author":"Bellissimo-Rodrigues","year":"2019","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.identj.2026.109662_bib0049","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/gutjnl-2023-330168","article-title":"Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial","volume":"73","author":"Zhu","year":"2024","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.identj.2026.109662_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18020483","article-title":"Potential suppressive effect of nicotine on the inflammatory response in oral epithelial cells: an in vitro study","volume":"18","author":"An","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.identj.2026.109662_bib0051","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3389\/fphys.2017.00663","article-title":"A comparison of oral sensory effects of three TRPA1 agonists in young adult smokers and non-smokers","volume":"8","author":"Hansen","year":"2017","journal-title":"Front Physiol"},{"issue":"5","key":"10.1016\/j.identj.2026.109662_bib0052","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/ADM.0000000000001401","article-title":"Buprenorphine Salivary gland accumulation sustaining high oral fluid exposure and increasing the risk of streptococcus mutans biofilm formation","volume":"19","author":"Zheng","year":"2025","journal-title":"J Addict Med"},{"issue":"Suppl 1","key":"10.1016\/j.identj.2026.109662_bib0053","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1478-3231.2011.02707.x","article-title":"Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice","volume":"32","author":"H\u00e9zode","year":"2012","journal-title":"Liver Int"},{"issue":"14","key":"10.1016\/j.identj.2026.109662_bib0054","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.3390\/jcm13144012","article-title":"Hepatitis C virus (HCV) infection: pathogenesis, oral manifestations, and the role of direct-acting antiviral therapy: a narrative review","volume":"13","author":"Di Stasio","year":"2024","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.identj.2026.109662_bib0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00784-025-06261-0","article-title":"In vitro analysis of various mouthwashes: cytotoxic, apoptotic, genotoxic and antibacterial effects","volume":"29","author":"\u00c7o\u011fulu","year":"2025","journal-title":"Clin Oral Investig"},{"issue":"5","key":"10.1016\/j.identj.2026.109662_bib0056","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1902\/jop.2009.080610","article-title":"Biologic assessment of antiseptic mouthwashes using a three-dimensional human oral mucosal model","volume":"80","author":"Moharamzadeh","year":"2009","journal-title":"J Periodontol"}],"container-title":["International Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020653926002558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020653926002558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:30:41Z","timestamp":1790681441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0020653926002558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0020653926002558"],"URL":"https:\/\/doi.org\/10.1016\/j.identj.2026.109662","relation":{},"ISSN":["0020-6539"],"issn-type":[{"value":"0020-6539","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacovigilance Analysis of Drug-Induced Stomatitis: Insights From Twenty-One Years of Real-World Data","name":"articletitle","label":"Article Title"},{"value":"International Dental Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.identj.2026.109662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of FDI World Dental Federation.","name":"copyright","label":"Copyright"}],"article-number":"109662"}}